AbbVie Analyst Ratings

BenzingaMay 17 07:15 ET

Johnson & Johnson Analyst Ratings

BenzingaMay 16 12:43 ET

Johnson & Johnson (JNJ) Receives a Buy From RBC Capital

TipRanksMay 16 06:30 ET

Eli Lilly and Co Analyst Ratings

BenzingaMay 14 12:56 ET

Argus Adjusts Price Target on Eli Lilly to $840 From $770

MT NewswiresMay 14 08:15 ET

Redburn Atlantic Adjusts Eli Lilly Price Target to $600 From $540

MT NewswiresMay 14 07:30 ET

Buy Rating Affirmed: AbbVie's Promising Growth Trajectory and Financial Outlook

TipRanksMay 14 06:55 ET

Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK), AbbVie (ABBV) and Establishment Labs Holdings (ESTA)

TipRanksMay 13 18:50 ET

Redburn Atlantic Adjusts Price Target on Pfizer to $27 From $26, Keeps Neutral Rating

MT NewswiresMay 13 05:57 ET

Redburn Adjusts Price Target on Amgen to $170 From $180, Keeps Sell Rating

MT NewswiresMay 13 05:53 ET

Stephens Adjusts Price Target on UnitedHealth to $565 From $545

MT NewswiresMay 10 09:18 ET

Amgen Analyst Ratings

BenzingaMay 9 07:48 ET

Redburn Atlantic Adjusts Price Target on Amgen to $180 From $170

MT NewswiresMay 9 06:44 ET

Mizuho Securities Raises Amgen's Price Target to $235 From $223

MT NewswiresMay 8 14:13 ET

China Merchants Initiates Eli Lilly at Buy Rating With $852 Price Target

MT NewswiresMay 8 11:06 ET

Daiwa Securities Adjusts Price Target on AbbVie to $171 From $190

MT NewswiresMay 8 08:32 ET

RBC Capital Keeps Their Buy Rating on Abbott Laboratories (ABT)

TipRanksMay 7 08:06 ET

Johnson & Johnson Analyst Ratings

BenzingaMay 6 09:57 ET

Amgen Analyst Ratings

BenzingaMay 3 10:08 ET

RBC Capital Reaffirms Their Buy Rating on Amgen (AMGN)

TipRanksMay 3 06:43 ET